A product containing 300 mg Ethylmorphine per 100 mL or 15 mg/dosage unit with active non-narcotic ingredients in recognized therapeutic amounts is scheduled as:

A product containing 300 mg Ethylmorphine per 100 mL or 15 mg/dosage unit with active non-narcotic ingredients in recognized therapeutic amounts is scheduled as:

• A. Schedule II
• B. Schedule IV
• C. Schedule I
• D. Schedule III

Answer: (D)

When a narcotic drug is combined with non-narcotic active ingredients in amounts that are recognized as therapeutic, the product’s schedule is determined by how much narcotic is present per unit and per volume. In this case, ethylmorphine up to 300 mg per 100 mL or 15 mg per dosage unit, together with active non-narcotic ingredients in recognized therapeutic amounts, fits the criteria for Schedule III. The non-narcotic components and the limited narcotic content reduce the overall abuse potential compared with higher schedules, so the product is placed in Schedule III. If the narcotic amount were higher or the product lacked qualifying non-narcotic ingredients, it would be classified higher, such as Schedule II.

When a narcotic drug is combined with non-narcotic active ingredients in amounts that are recognized as therapeutic, the product’s schedule is determined by how much narcotic is present per unit and per volume. In this case, ethylmorphine up to 300 mg per 100 mL or 15 mg per dosage unit, together with active non-narcotic ingredients in recognized therapeutic amounts, fits the criteria for Schedule III. The non-narcotic components and the limited narcotic content reduce the overall abuse potential compared with higher schedules, so the product is placed in Schedule III. If the narcotic amount were higher or the product lacked qualifying non-narcotic ingredients, it would be classified higher, such as Schedule II.